#AAN2018 – Neural Stem Cell-Based Therapy is Safe, May Benefit Patients, Early Test Results Suggest

#AAN2018 – Neural Stem Cell-Based Therapy is Safe, May Benefit Patients, Early Test Results Suggest
Human neural stem cells show promise as therapy for Parkinson’s disease, according to six-month interim results of Phase 1 trial. The therapy’s developer, International Stem Cell’s Corporation subsidiary Cyto Therapeutics, will present the results at the American Academy of Neurology annual meeting in Los Angeles, April 21-27. Parkinson’s News Today will be covering the conference. The presentation, taking place during the Scientific Platform Sessions, will ... read more
Source: Parkinson’s News TodayPublished on 2018-04-17By Patricia Inacio, PhD